Paracetamol and Salicylate Level Detection Assays

High-sensitivity assays for rapid and accurate pathogen detection in human health applications. These molecular diagnostic tools deliver user-friendly testing with reliable results aligned to international diagnostic standards.

Comprehensive range of detection assays developed for identification of global pathogens across multiple analytical technologies. Manufactured under ISO 13485 and cGMP standards for clinical laboratory use.

A comprehensive portfolio of high-performing, Six-Sigma assays compatible with all AU Chemistry Analyzers, including tests for general chemistry, protein chemistry, serology, drugs of abuse, therapeutic drug monitoring, thyroid, immunosuppressant drugs, and esoteric testing. These assays support a broad range of clinical testing needs across multiple laboratory disciplines.

More than 300 different tests for various indications. These products are developed for use in medical laboratory diagnostics and research. They are produced under strict manufacturing and quality control guidelines.

Liquid chromatography-tandem mass spectrometry based assays for laboratory diagnostics and disease risk identification. These tests provide precise quantitative analysis of biological markers and metabolites in clinical specimens.

Molecular assays for detection and identification of infectious pathogens in clinical specimens. Integrated into laboratory workflows for rapid and accurate diagnosis.

Assays designed to measure blood levels of antipsychotic drugs prescribed for serious mental illnesses such as Schizophrenia and Bipolar Disorders. Utilizing nanoparticle technology, these assays provide data for healthcare professionals to monitor the efficacy of drugs commonly used in the treatment of psychosis, including Clozapine, Risperidone/Paliperidone, Olanzapine, and Aripiprazole. The platform is suitable for both point-of-care settings and traditional analyzers in clinical laboratories.

Specialized enzymatic and immunological assays for detecting metabolic disorders including amino acid and organic acid metabolism disorders in newborn screening programs.

DPP Technology-based assays are rapid diagnostic tests utilizing dual-path platform methodology for qualitative and quantitative detection of biomarkers, pathogens, and analytes. These in vitro diagnostic devices deliver results within minutes, supporting clinical decision-making across laboratory, point-of-care, and hospital settings. Applications include infectious disease screening, therapeutic drug monitoring, and immunoassays across multiple therapeutic areas.

A quality control material for barbiturate panel testing in clinical laboratories. Level 2 formulation used for analytical validation and quality assurance of barbiturate detection assays.

An integrated biochemistry testing platform for clinical laboratory diagnostics. The system encompasses multiple biochemical assays approved for clinical use in patient sample analysis.

Comprehensive chromatographic diagnostic kits for HPLC, GC, GC-MS, and LC-MS/MS analytical instruments. Includes screening and confirmatory assays for drugs of abuse, plus calibrators and quality controls for specialized clinical chemistry and therapeutic drug monitoring applications.